Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Obsessive Compulsive Disorder
Interventions: Low Intensity Focused Ultrasound, Sham (No Treatment); Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 22 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Neurotic Disorders, Obsessive-Compulsive Disorder
Interventions: Lamictal (lamotrigine); Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obsessive-Compulsive Disorder, Pain, Intractable, Depression
Interventions: fMRI and DTI, Behavioral questionnaires, Disease-Specific Patient-Reported Outcomes, Behavioral tests; Diagnostic Test · Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Trichotillomania
Interventions: StopPulling.com; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obsessive-Compulsive Disorder
Interventions: Fluoxetine 60 mg, Naltrexone 32 mg and fluoxetine 60 mg, Naltrexone SR 32 mg; Drug
Lead sponsor: Orexigen Therapeutics, Inc; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 11
States / cities: National City, California • San Diego, California • Gainesville, Florida + 8 more

Conditions: Parkinson's Disease, Essential Tremor, Dystonia, Obsessive Compulsive Disorder
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Mental Disorder Diagnosed in Childhood, Obsessive Compulsive Disorder, Streptococcal Infection, Tic Disorder
Interventions: Penicillin or Placebo; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obsessive-Compulsive Disorder
Interventions: Bitopertin, Placebo, SSRI; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 27
States / cities: Oceanside, California • Stanford, California • New Haven, Connecticut + 22 more

Conditions: Tourette Syndrome, Obsessive-Compulsive Disorder, Sensory Disorders
Interventions: None - observational study; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Anxiety Disorders, Obsessive Compulsive Disorder
Interventions: Not listed
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 8 Years to 12 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Prader Willi Syndrome, Obsessive-compulsive Disorder
Interventions: Cognitive-behavioral therapy, Wait-list control; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 6 Years to 17 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder, Obsessive-Compulsive Disorder in Children, Obsessive-Compulsive Disorder in Adolescence
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 7 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obsessive Compulsive Disorder
Interventions: Troriluzole (BHV-4157); Drug
Lead sponsor: Biohaven Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 772 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 147
States / cities: Chandler, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 119 more

Conditions: Obsessive-compulsive Disorder, Ocd
Interventions: riluzole, placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obsessive-Compulsive Disorder (OCD)
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Trichotillomania
Interventions: Device and app system designed for participant to self-administer Habit Reversal Training, Reminder bracelet control condition; Behavioral
Lead sponsor: HabitAware Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Saint Louis Park, Minnesota

Conditions: Obsessive-Compulsive Disorder
Interventions: Cognitive Behavioral Therapy (CBT), Waitlist; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 6 Years to 18 Years
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Trichotillomania (Hair-Pulling Disorder), Dermatillomania
Interventions: Placebo, Aripiprazole; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hoarding Disorder, Attentional Impairment
Interventions: Cognitive Remediation, Control (Placebo); Behavioral
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Obsessive-Compulsive Disorder
Interventions: Smartphone-delivered CBT for OCD; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: OCD
Interventions: Light therapy; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 17 Years to 35 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obsessive-Compulsive Disorder
Interventions: Clomipramine; Drug
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 2
States / cities: Stanford, California • Cincinnati, Ohio

Conditions: Obsessive-Compulsive Disorder
Interventions: Exposure therapy; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: San Diego, California • Belmont, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Serotonin reuptake inhibitors management, Cognitive behavioral therapy by a psychologist, Instructional cognitive behavioral therapy by a psychiatrist; Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 3
States / cities: Durham, North Carolina • Philadelphia, Pennsylvania • Providence, Rhode Island

Search by objective public record fields.

SONATA LIFU for OCD

An Open-Label Study Of Lamictal In Neurotic Excoriation

Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease

Stepped Care in the Treatment of Trichotillomania

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder

Sensory Gating Measured With Microelectrode Recording (MER) During Deep Brain Stimulation (DBS) Surgery

Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)

A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder

Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders

Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder

Acceptance and Commitment Therapy for Religious OCD

Feasibility Study for Treating Trichotillomania With Wearable Device and App System

Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder

Aripiprazole in Body Focused Repetitive Behaviors

Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding

Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)

Light Therapy for Obsessive-compulsive Disorder (OCD)

Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder

Mechanisms of Exposure Therapy for OCD

Treatment of Obsessive Compulsive Disorder in Children